Sort
30,917 grants matching “tumor microenvironment”
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$374,388Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2012 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$374,372Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2022 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$374,372Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2023 · CA
In Vivo Genetic Analysis of Compartmentalized Cell Elimination
$374,356Piya Ghose · University Of Texas Arlington · R35 · FY2024 · GM
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
$374,355Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2024 · OD
Imaging of progenitor cells in tumor environments
$374,249Massachusetts General Hospital · R01 · FY2002 · CA
Project 1 High-order assembly of MegaTrans complexes for hormone-independent enhancer activation
$374,247Zhijie "jason" Liu · University Of Texas Hlth Science Center · U54 · FY2019 · CA
Regulation of Metastatic Development by Heritable Variants in the Tumor Microenvironment
$374,245Paula Jill Hurley · Johns Hopkins University · R01 · FY2018 · CA
Improving epidermal growth factor receptor-targeted of HNSCC by inhibition of tr
$374,233Atul Bedi · Johns Hopkins University · P50 · FY2013 · DE
Experimental Therapeutics by targeting Spleen Tyrosine Kinase
$374,208Ie-Ming Shih · Johns Hopkins University · R01 · FY2017 · CA
Cell Competition in Myeloproliferative Neoplasms
$374,203Huichun Zhan · State University New York Stony Brook · R01 · FY2022 · CA
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
$374,185Brian Koss · Univ Of Arkansas For Med Scis · DP5 · FY2025 · OD
PGE2 Regulation of Host Defense post-BMT
$374,120Bethany B. Moore · University Of Michigan At Ann Arbor · R01 · FY2007 · AI
Investigating the functions of the miR-17~92 family of oncogenic microRNA clusters
$374,080Andrea Ventura · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Optimizing radiation therapy through the manipulation of glutamine metabolism
$374,063Julie Kristina Schwarz · Washington University · R01 · FY2022 · CA
Role of the smooth muscle layer in bladder cancer biology and progression: a systems and experimental approach
$374,052Ashley Marie Laughney · Weill Medical Coll Of Cornell Univ · R21 · FY2022 · CA
Correlates of antitumor immunity in colorectal cancers and anti PD1 therapy
$374,006Franck Housseau · Johns Hopkins University · R01 · FY2017 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$374,006Bo Li · Ut Southwestern Medical Center · R01 · FY2020 · CA
IPMK function in chromatin
$374,000Raymond Daniel Blind · Vanderbilt University Medical Center · R01 · FY2023 · GM
IPMK function in chromatin
$374,000Raymond Daniel Blind · Vanderbilt University Medical Center · R01 · FY2020 · GM
Hematopoietic Stem Cell-based CAR Macrophage for Alzheimer's Disease
$374,000Anjie Zhen · University Of California Los Angeles · R61 · FY2025 · AG
IPMK function in chromatin
$374,000Raymond Daniel Blind · Vanderbilt University Medical Center · R01 · FY2022 · GM
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
$373,877Shannon Celeste Kenney · University Of Wisconsin-Madison · R01 · FY2022 · CA
Biomaterial Mimicry of Dynamic Matrix Stiffening During Tumor Progression
$373,869Adam J Engler · University Of California, San Diego · R01 · FY2016 · CA
Sympathetic modulation of head and neck cancer pain
$373,849Nicole N Scheff · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DE